HMGA1 and non-small cell lung carcinoma: Using immunohistochemistry, Zhang et al [35] experimentally observed that high levels of HMGA1 protein are positively correlated with the status of clinical stage and differentiation degree in NSCLC, and suggested that HMGA1 may act as a convictive biomarker for the prognostic prediction of NSCLC.